Briefly, freshly isolated PBMCs from MS and healthy control individuals were transplanted into severely immunodeficient B2m-NOG mice, resulting in progressive engraftment by human CD4 and CD8 T cells and B cells, with significant variability between different PBMC donors. This evidence concerns the gene CD4 and myeloid sarcoma.